Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
DeBaun
Michael R
MR
D000755:Anemia, Sickle Cell / Q000150:complications*; D000986:Antisickling Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D015994:Incidence; D055502:Secondary Prevention; D020521:Stroke / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*
D000986:Antisickling Agents; D006918:Hydroxyurea